Beneficial gut bacteria use mucus lining to stay in place, study finds

When it comes to gut health, it doesn’t just matter who’s invited to the party, but how they behave.

Activist investor Alex Denner, Bioverativ shareholder reach tentative settlement in insider trading case

A tentative settlement has been reached in a long-running shareholder lawsuit that accused health care activist investor Alex Denner of making nearly $50 million from

April 29, 2024

Bayer to pull follicular lymphoma drug Aliqopa from US market in another blow to PI3K inhibitor space

Bayer said it will voluntarily withdraw its follicular lymphoma drug Aliqopa from the US after a confirmatory trial disappointment, marking the third PI3K inhibitor to

November 9, 2023

PharmaDrug’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – May 15, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.